What as the predictor factors for response to therapy with tocilizumab in real clinical practice? Experiences from national registry ATTRA
2013
Abstract
Observational, prospective, cohort study, which evaluated laboratory and clinical outcomes and there combinations at baseline for prediction for response of Il-6 therapy.